Keybank National Association Horizon Therapeutics Public LTD CO Transaction History

Keybank National Association

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	SELL	$62.39 - $113.8 $50,910 - $92,860	-816 Reduced 7.66%	9,837 $1.12 Million
Q3 2022 Oct 27, 2022	SELL	$58.92 - $84.67 $14,258 - $20,490	-242 Reduced 2.22%	10,653 $659,000
Q2 2022 Aug 08, 2022	SELL	$79.4 - $116.36 $46,449 - $68,070	-585 Reduced 5.1%	10,895 $869,000
Q1 2022 Apr 28, 2022	SELL	$86.42 - $109.81 $582,557 - $740,229	-6,741 Reduced 37.0%	11,480 $1.21 Million
Q4 2021 Feb 07, 2022	SELL	$98.56 - $119.91 $1.76 Million - $2.14 Million	-17,874 Reduced 49.52%	18,221 $1.96 Million

Q3 2021 Nov 08, 2021	SELL	$91.91 - $110.37 $385,194 - $462,560	-4,191 Reduced 10.4%	36,095 $3.95 Million
Q2 2021 Aug 12, 2021	BUY	$86.24 - $95.92 $219,739 - $244,404	2,548 Added 6.75%	40,286 $3.77 Million
Q1 2021 May 07, 2021	SELL	$71.83 - $95.48 $277,694 - $369,125	-3,866 Reduced 9.29%	37,738 $3.47 Million
Q4 2020 Feb 09, 2021	BUY	$67.0 - $84.39 $377,478 - $475,453	5,634 Added 15.66%	41,604 $3.04 Million
Q3 2020 Oct 29, 2020	SELL	$55.23 - $79.93 $696,229 - $1.01 Million	-12,606 Reduced 25.95%	35,970 $2.79 Million
Q2 2020 Aug 10, 2020	BUY	$30.2 - $56.98 $700,670 - $1.32 Million	23,201 Added 91.43%	48,576 $2.7 Million
Q1 2020 May 13, 2020	BUY	$24.87 - $38.56 $400,407 - $620,816	16,100 Added 173.58%	25,375 $752,000
Q4 2019 Feb 05, 2020	SELL	$25.43 - $36.67 $5,823 - $8,397	-229 Reduced 2.41%	9,275 $336,000
Q3 2019 Nov 04, 2019	SELL	$23.0 - $27.97 $26,358 - $32,053	-1,146 Reduced 10.76%	9,504 $259,000
Q2 2019 Aug 01, 2019	BUY	$22.81 - $28.48 $242,926 - $303,312	10,650 New	10,650 $256,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

Stay updated on Keybank National Association with notifications on news.